GROWTH-HORMONE (GH) SECRETION IN ACTIVE ACROMEGALY AFTER THE COMBINED ADMINISTRATION OF GH-RELEASING HORMONE AND GH-RELEASING PEPTIDE-6

被引:26
|
作者
POPOVIC, V
DAMJANOVIC, S
MICIC, D
PETAKOV, M
DIEGUEZ, C
CASANUEVA, FF
机构
[1] UNIV SANTIAGO DE COMPOSTELA, FAC MED, DEPT PHYSIOL, E-15780 SANTIAGO, SPAIN
[2] UNIV SANTIAGO DE COMPOSTELA, FAC MED, DEPT MED, SANTIAGO, SPAIN
[3] UNIV BELGRADE, CTR CLIN, INST ENDOCRINOL, YU-11000 BELGRADE, YUGOSLAVIA
来源
关键词
D O I
10.1210/jc.79.2.456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (called GHRP-6) is a synthetic compound that releases GH in a dose-related, specific, and nonspecies-specific manner, through mechanisms different from those of GHRH. Being, normally, more potent than GHRH, GHRP-6 shows a striking synergistic action when administered simultaneously with GHRH, although the mechanisms and point of action of such a potentiating effect are unknown. The aim of the present study was 2-fold: 1) to further characterize the actions and mechanisms of GHRP-6 as well as its synergistic effects, and 2) to study its actions in acromegalic patients. Eleven acromegalic patients and 12 normal subjects, age and sex matched as controls, underwent 3 tests each on separate occasions, being challenged with GHRH (100 mu g, iv), GHRP-6 (90 mu g, iv), or GHRH plus GHRP-6. GH was analyzed as the area under the curve (mean +/- SE; micrograms per L/120 min). In normal subjects, GH secretion was 686 +/- 227 after GHRH, 1787 +/- 510 after GHRP-6, and 4111 +/- 671 after GHRH plus GHRP-6; the level of GH secreted after GHRH plus GHRP-6 treatment was significantly (P < 0.05) higher than the arithmetic sum of GH levels after both compounds administered separately. In acromegalic patients, the level of GH secreted after GHRH was 1468 +/- 499, that after GHRP-6 was 2595 +/- 762, and that after GHRH plus GHRP-6 was 4949 +/- 1043; this last value was not significantly different from the arithmetical addition of levels produced by both compounds administered separately. These results indicate that GH-secreting pituitary adenomas respond surprisingly well to either GHRH or GHRP-6 despite being deprived for long periods (even years) of the physiological regulation exerted by the hypothalamus. In addition, the synergistic action of GHRH plus GHRP-6 was observed in normal subjects, but not in acromegalic patients. These results suggest that GHRP-6 does not need to operate through hypothalamic factors to exert its GH-releasing action, even for eliciting a greater response than GHRH. On the other hand, the synergistic effect of GHRH plus GHRP-6 appears to need the cooperation of the hypothalamus, but how this occurs is still undetermined.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
  • [1] GROWTH-HORMONE (GH) RESPONSES TO THE COMBINED ADMINISTRATION OF GH-RELEASING HORMONE PLUS GH-RELEASING PEPTIDE-6 IN ADULTS WITH GH DEFICIENCY
    LEALCERRO, A
    GARCIA, E
    ASTORGA, R
    CASANUEVA, FF
    DIEGUEZ, C
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (06) : 712 - 715
  • [2] Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion
    Muller, AF
    Janssen, JAMJL
    Lamberts, SWJ
    Bidlingmaier, M
    Strasburger, CJ
    Hofland, L
    van der Lely, AJ
    [J]. CLINICAL ENDOCRINOLOGY, 2001, 55 (04) : 461 - 467
  • [3] EFFECT OF COMBINED ADMINISTRATION OF GROWTH-HORMONE (GH)-RELEASING HORMONE, GH-RELEASING PEPTIDE-6, AND PYRIDOSTIGMINE IN NORMAL AND OBESE SUBJECTS
    CORDIDO, F
    PENALVA, A
    PEINO, R
    CASANUEVA, FF
    DIEGUEZ, C
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (06): : 745 - 748
  • [4] GROWTH-HORMONE (GH) RESPONSES TO GH-RELEASING PEPTIDE AND TO GH-RELEASING HORMONE IN GH-DEFICIENT CHILDREN
    MERICQ, V
    CASSORLA, F
    GARCIA, H
    AVILA, A
    BOWERS, CY
    MERRIAM, GR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (05): : 1681 - 1684
  • [5] GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults
    Popovic, V
    Leal, A
    Micic, D
    Koppeschaar, HPF
    Torres, E
    Paramo, C
    Obradovic, S
    Dieguez, C
    Casanueva, FF
    [J]. LANCET, 2000, 356 (9236): : 1137 - 1142
  • [6] Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion
    Catalina, PF
    Mallo, F
    Andrade, MA
    García-Mayor, RV
    Diéguez, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10): : 3663 - 3667
  • [7] Different growth hormone (GH) responses to GH-releasing peptide and GH-releasing hormone in hyperthyroidism
    RamosDias, JC
    Pimentel, F
    Reis, AF
    Lengyel, AMJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04): : 1343 - 1346
  • [8] GROWTH-HORMONE (GH) AND PROLACTIN RESPONSES TO REPETITIVE ADMINISTRATION OF GH-RELEASING HORMONE IN ACROMEGALY
    LOSA, M
    SCHOPOHL, J
    KONIG, A
    MULLER, OA
    VONWERDER, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (02): : 475 - 480
  • [9] Growth hormone (GH) releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation
    Pandya, N
    DeMott-Friberg, R
    Bowers, CY
    Barkan, AL
    Jaffe, CA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1186 - 1189
  • [10] ACUTE GROWTH-HORMONE (GH) RESPONSE TO GH-RELEASING HEXAPEPTIDE IN HUMANS IS INDEPENDENT OF ENDOGENOUS GH-RELEASING HORMONE
    ROBINSON, BM
    FRIBERG, RD
    BOWERS, CY
    BARKAN, AL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (04): : 1121 - 1124